ALEXANDER EPPERLY: Open Payments
NPI 1285993519 · SOUTH CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,800 in 89 payments from 12 companies in 2025. Trend: 2023 $2,727 · 2024 $2,980 · 2025 $9,800
Speaker / faculty: $6,600Food & beverage: $1,916Travel & lodging: $931Consulting: $275Education: $78
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $8,349 |
| Novartis Pharmaceuticals Corporation | 7 | $291 |
| Amgen Inc. | 14 | $239 |
| Regeneron Healthcare Solutions, Inc. | 7 | $238 |
| UCB, Inc. | 10 | $227 |
| Janssen Biotech, Inc. | 9 | $218 |
| Galderma Laboratories, L.P. | 10 | $151 |
| Lilly USA, LLC | 2 | $35 |
| Incyte Corporation | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
Products named: SKYRIZI, Otezla, DUPIXENT, TREMFYA, RINVOQ, NEMLUVIO, Bimzelx, COSENTYX.
Industry payments across WV — which companies pay providers there.
